STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value (STRM)

Historical Holders from Q1 2014 to Q3 2025

Symbol
STRM on Nasdaq
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
4,279,000
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value (STRM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Tamarack Advisers, LP 3.6% $35,430 154,044 Ferayorni Justin John 13 Nov 2024

Institutional Holders of STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value (STRM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$1,038,000 0
2025 Q2 200,000 $1,038,000 +$1,038,000 $5.19 1
2025 Q1 0 $0 -$230 0
2024 Q4 0 $0 -$2,015,639 0
2024 Q3 8,760,612 $2,015,639 -$1,722,043 $0.2301 23
2024 Q2 12,386,588 $5,719,610 +$4,130 $0.4608 29
2024 Q1 12,286,476 $5,898,517 -$196,296 $0.48 28
2023 Q4 17,743,035 $7,561,600 -$349,112 $0.425 39
2023 Q3 17,883,693 $17,266,568 -$1,226,521 $0.9675 43
2023 Q2 19,143,429 $24,292,810 +$148,873 $1.27 39
2023 Q1 18,942,356 $34,066,810 +$1,806,661 $1.8 37
2022 Q4 17,944,848 $28,343,327 +$2,613,366 $1.58 37
2022 Q3 16,375,130 $19,466,900 +$5,714,521 $1.19 29
2022 Q2 11,568,957 $14,685,700 -$202,813 $1.27 24
2022 Q1 11,703,066 $18,724,000 -$7,236,951 $1.6 27
2021 Q4 16,598,901 $24,686,000 -$1,330,145 $1.47 26
2021 Q3 17,411,227 $30,465,500 -$1,748,772 $1.75 29
2021 Q2 18,406,782 $32,568,700 -$1,261,446 $1.77 32
2021 Q1 18,962,602 $38,835,500 +$11,453,580 $2.05 33
2020 Q4 14,051,323 $22,135,600 +$423,040 $1.56 29
2020 Q3 13,865,990 $21,632,600 +$203,880 $1.56 27
2020 Q2 13,312,215 $17,706,566 +$580,695 $1.33 25
2020 Q1 13,333,474 $11,331,670 -$1,105,824 $0.8499 27
2019 Q4 14,133,488 $19,646,178 +$7,212,586 $1.39 26
2019 Q3 8,973,869 $9,745,220 +$159,990 $1.08 27
2019 Q2 8,810,068 $13,411,402 -$28,814 $1.51 28
2019 Q1 8,868,209 $9,310,710 -$59,108 $1.05 27
2018 Q4 8,976,228 $7,231,825 -$255,045 $0.808 30
2018 Q3 7,427,930 $8,808,036 -$117,859 $1.18 32
2018 Q2 7,522,393 $10,738,994 -$72,827 $1.41 28
2018 Q1 7,603,017 $13,973,368 +$700,806 $1.84 29
2017 Q4 7,195,641 $12,132,000 -$8,314 $1.69 32
2017 Q3 7,139,913 $10,495,000 -$449,962 $1.47 23
2017 Q2 7,573,831 $8,103,000 -$1,541,363 $1.07 27
2017 Q1 9,111,200 $9,292,000 +$298,970 $1.02 33
2016 Q4 9,185,228 $11,463,000 +$335,140 $1.25 35
2016 Q3 9,028,616 $16,568,000 +$857,780 $1.84 39
2016 Q2 8,565,111 $10,278,000 -$1,058,889 $1.2 35
2016 Q1 9,192,354 $12,962,000 -$383,602 $1.41 35
2015 Q4 9,568,204 $13,484,000 -$6,326,341 $1.41 33
2015 Q3 11,091,123 $25,398,000 -$364,151 $2.29 37
2015 Q2 11,193,300 $31,337,892 -$492,974 $2.8 37
2015 Q1 11,273,029 $40,083,000 -$1,116,357 $3.55 34
2014 Q4 11,261,126 $48,748,211 -$507,490 $4.33 39
2014 Q3 11,076,842 $51,283,000 -$202,093 $4.63 39
2014 Q2 11,092,105 $53,507,000 +$3,797,425 $4.8 40
2014 Q1 10,342,660 $52,027,000 +$1,099,164 $5.03 39